You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Medication safety of prescription in pregnant women with constipation
- In: Poster presentation
- At: Buenos Aires (Argentina) (2016)
- Type: Poster
- Poster code: POS-HPS-035
- By: HUANG, Shu Fen (Chi-Mei medical center, Pharmacy, Tainan, China Taiwan)
- Co-author(s): Shu Fen Huang:
- Abstract:
The prevalence of constipation in pregnancy ranges from 11% to 44%. Common medications like lubricants, bulk-forming agents, osmotic laxatives, stimulant laxatives, stool softeners, and enemas and suppositories are not necessarily suitable for use in pregnant women. FDA categorized the risks of taking a drug or biological product during pregnancy..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026